IOSAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Iosat, and when can generic versions of Iosat launch?
Iosat is a drug marketed by Anbex and is included in one NDA.
The generic ingredient in IOSAT is potassium iodide. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Iosat
A generic version of IOSAT was approved as potassium iodide by MISSION PHARMACAL on March 24th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for IOSAT?
- What are the global sales for IOSAT?
- What is Average Wholesale Price for IOSAT?
Summary for IOSAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 149 |
| Patent Applications: | 3,902 |
| What excipients (inactive ingredients) are in IOSAT? | IOSAT excipients list |
| DailyMed Link: | IOSAT at DailyMed |
US Patents and Regulatory Information for IOSAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anbex | IOSAT | potassium iodide | TABLET;ORAL | 018664-002 | May 12, 2011 | OTC | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Anbex | IOSAT | potassium iodide | TABLET;ORAL | 018664-001 | Oct 14, 1982 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
